ThomasEGribbinMD

Oncology • Grand Rapids, MI

Physician

Join to view full profile

Dr. Gribbin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gribbin's full profile

Already have an account?

Office
250 Cherry St SE
Ste 2200
Grand Rapids, MI 49503
Phone+1 616-685-5600

Fax+1 616-685-6745
Is this information wrong?

Education & Training

University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1985 - 1988
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1981 - 1984
University of Illinois College of MedicineClass of 1981

Certifications & Licensure

MI State Medical License 1986 - 2026
IL State Medical License 1982 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013

Clinical Trials

A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
Unknown status
Phase 1, Phase 2
Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Start of enrollment: 2011 Nov 01
Terminated
Phase 2
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma Start of enrollment: 2013 Jul 12
Completed
Phase 3
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Start of enrollment: 2013 Dec 13
Active, not recruiting
Phase 3
Project Survival-Prospective Biomarker Discovery Start of enrollment: 2016 Mar 01
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

13 citations
Effect of a Collaboration Between a Health Plan, Oncology Practice, and Comprehensive Genomic Profiling Company from the Payer Perspective.
Mitchell Reitsma, John Fox, Pierre Vanden Borre, Matthew Cavanaugh, Yakov Chudnovsky, Rachel L. Erlich, Thomas E. Gribbin, Rachel Anhorn> ;Journal of Managed Care & Specialty Pharmacy. 2019 Jan 11
19 citations
90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;European Journal of Cancer. 2015 Sep 1
2 citations
Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy
Laura E. Zyczynski, Jonathan B. McHugh, Thomas E. Gribbin, Scott M. Schuetze> ;Case Reports in Oncological Medicine. 2015 Jul 22
5 citations
A CD20 tandem-epitope immunogen elicits antibody in mice that binds murine cell surface CD20 and depletes splenic B cells in vivo
Jon Oscherwitz, Thomas E. Gribbin, Kemp B. Cease> ;Molecular Immunology. 2010 Apr 1
10 citations
Breast cancer metastatic to renal cell carcinoma.
Mecker G. Möller, Thomas Gribbin, Steve Ebrom, Gilbert D.A. Padula, Timothy L. Fitzgerald> ;Surgery. 2006 Apr 1
15 citations
A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein
Jon Oscherwitz, Mary E. Zeigler, Thomas E. Gribbin, Kemp B. Cease> ;Vaccine. 1999 May 14
94 citations
Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases
Jozef Spychala, Nabanita S. Datta, Kenji Takabayashi, Milton W. Datta, Irving H. Fox, Thomas E. Gribbin, Beverly S. Mitchell> ;Proceedings of the National Academy of Sciences of the United States of America. 1996 Feb 6
34 citations
Genomic structure and chromosomal localization of the human deoxycytidine kinase gene.
James J. Song, Scott C. Walker, Everett H. Chen, Earnest E. Johnson, Jozef Spychala, Thomas E. Gribbin, Beverly S. Mitchell> ;Proceedings of the National Academy of Sciences of the United States of America. 1993 Jan 15
2 citations
New purine analogues for the treatment of chronic B-cell malignancies.
Thomas E. Gribbin> ;Henry Ford Hospital Medical Journal. 1991 Jan 1
47 citations
CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Curtis A. Hanson, Thomas E. Gribbin, Bertram Schnitzer, June A. Schlegelmilch, Beverly S. Mitchell, Lloyd M. Stoolman> ;Blood. 1990 Dec 1
5 citations
Association of a mature B cell leukemia with a 4p+ chromosomal abnormality: derivation and characterization of a cell line.
Thomas E. Gribbin, Constance K. Stein, J. S. Harrison, Thomas W. Glover, Curtis A. Hanson, J. J. Wasmuth, Robert L. Cody, Beverly S. Mitchell> ;Leukemia. 1989 Sep 1
3 citations
Erythrocyte-specific overproduction of adenosine deaminase: molecular genetic studies.
E G Chottiner, Thomas E. Gribbin, David Ginsburg, Beverly S. Mitchell> ;Progress in Clinical and Biological Research. 1989 Jan 1
Join now to see all

Press Mentions

End-of-Life Talks May Finally Overcome PoliticsAugust 30th, 2014

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Sparrow Carson HospitalCarson City, Michigan
Holland HospitalHolland, Michigan
Corewell Health - Butterworth HospitalGrand Rapids, Michigan
Corewell Health Zeeland HospitalZeeland, Michigan
Trinity Health MuskegonMuskegon, Michigan
Trinity Health Grand Rapids HospitalGrand Rapids, Michigan
Trinity Health Grand HavenGrand Haven, Michigan

ThomasEGribbinMD

Dr. Gribbin is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.